BAX

SEC source: 0001628280-26-060476 · wk-form4_1788466687.xml · nonDerivative · entry 1

Hider Andrew P. · CIK 0001940945 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 518,447

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2026 from the settlement of vested restricted stock units granted on September 2, 2025.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-060469 · wk-form4_1788466597.xml · nonDerivative · entry 1

Foster Julie · CIK 0002127118 · President, Front Line Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,164

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2026 from the settlement of vested restricted stock units granted on September 2, 2025.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-060479 · wk-form4_1788466775.xml · nonDerivative · entry 1

Teaff James · CIK 0002127784 · President, CCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,370

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 1, 2026 from the settlement of vested restricted stock units granted on September 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001628280-26-040222 · wk-form4_1780517195.xml · nonDerivative · entry 1

Wallace Steven P. · CIK 0001763512 · President, Adv. Surgery

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,128

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025.

SEC source: 0001628280-26-040214 · wk-form4_1780517122.xml · nonDerivative · entry 1

Teaff James · CIK 0002127784 · President, CCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,063

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025.

F2 · balance_after: Total includes shares held in the Baxter's Employee Stock Plan.

SEC source: 0001628280-26-040231 · wk-form4_1780517240.xml · nonDerivative · entry 1

Zielinski Anita A · CIK 0001703384 · SVP, Interim CFO, CAO & Cntrlr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,714

F1 · shares: In connection with Ms. Zielinski's appointment to Interim CFO and commensurate with related additional duties, she received a one-time special grant award of restricted stock units which are scheduled to vest on the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032196 · wk-form4_1778185337.xml · nonDerivative · entry 1

Wilkes David S. · CIK 0001842866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,076

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032190 · wk-form4_1778185265.xml · nonDerivative · entry 1

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,235

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032184 · wk-form4_1778185209.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,994

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032176 · wk-form4_1778185179.xml · nonDerivative · entry 1

MORRISON PATRICIA · CIK 0001204081 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,386

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032168 · wk-form4_1778185142.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director · Chair of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,804

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032135 · wk-form4_1778184781.xml · nonDerivative · entry 1

Craig Jeffrey A · CIK 0001360603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,662

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-032141 · wk-form4_1778184846.xml · nonDerivative · entry 1

McDonnell Michael R. · CIK 0001121897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,647

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001628280-26-032127 · wk-form4_1778184709.xml · nonDerivative · entry 1

Ampofo William A. II · CIK 0001983479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,375

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-016420 · wk-form4_1773173332.xml · nonDerivative · entry 1

Zielinski Anita A · CIK 0001703384 · SVP, CAO and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,281

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2025.

SEC source: 0001628280-26-016412 · wk-form4_1773173275.xml · nonDerivative · entry 1

Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,045

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.

SEC source: 0001628280-26-016408 · wk-form4_1773173228.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,216

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.

SEC source: 0001628280-26-016405 · wk-form4_1773173171.xml · nonDerivative · entry 1

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,557

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.

SEC source: 0001628280-26-016401 · wk-form4_1773173116.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,674

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.

SEC source: 0001628280-26-014243 · wk-form4_1772582952.xml · nonDerivative · entry 1

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,231

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.

SEC source: 0001628280-26-014241 · wk-form4_1772582902.xml · nonDerivative · entry 2

Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,894

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.

SEC source: 0001628280-26-014239 · wk-form4_1772582854.xml · nonDerivative · entry 2

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,837

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.

SEC source: 0001628280-26-014248 · wk-form4_1772583051.xml · derivative · entry 2

Hider Andrew P. · CIK 0001940945 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,506

Underlying: Common Stock, $1 par value · 488,506 shares

Expires 2036-02-27

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

SEC source: 0001628280-26-014248 · wk-form4_1772583051.xml · nonDerivative · entry 1

Hider Andrew P. · CIK 0001940945 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,239

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

F2 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001628280-26-014245 · wk-form4_1772583002.xml · derivative · entry 3

Carlisle Cynthia · CIK 0002013998 · Executive Vice President, CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,103

Underlying: Common Stock, $1 par value · 43,103 shares

Expires 2036-02-27

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

SEC source: 0001628280-26-014245 · wk-form4_1772583002.xml · nonDerivative · entry 2

Carlisle Cynthia · CIK 0002013998 · Executive Vice President, CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,677

F2 · shares: The reporting person received a grant of 11,871 restricted stock units all of which are scheduled to vest on February 27, 2029, subject to satisfaction of the related vesting requirements set forth in the Plan.

SEC source: 0001628280-26-014245 · wk-form4_1772583002.xml · nonDerivative · entry 1

Carlisle Cynthia · CIK 0002013998 · Executive Vice President, CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,806

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the "Plan").

SEC source: 0001628280-26-014241 · wk-form4_1772582902.xml · derivative · entry 3

Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,471

Underlying: Common Stock, $1 par value · 57,471 shares

Expires 2036-02-27

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

SEC source: 0001628280-26-014241 · wk-form4_1772582902.xml · nonDerivative · entry 1

Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,748

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001628280-26-014239 · wk-form4_1772582854.xml · derivative · entry 3

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,655

Underlying: Common Stock, $1 par value · 64,655 shares

Expires 2036-02-27

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

SEC source: 0001628280-26-014239 · wk-form4_1772582854.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,173

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001628280-26-014236 · wk-form4_1772582805.xml · derivative · entry 2

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,448

Underlying: Common Stock, $1 par value · 103,448 shares

Expires 2036-02-27

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

SEC source: 0001628280-26-014236 · wk-form4_1772582805.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,828

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

F2 · balance_after: Total includes shares held in the Baxter's Employee Stock Plan.

SEC source: 0001628280-26-014234 · wk-form4_1772582681.xml · nonDerivative · entry 1

Zielinski Anita A · CIK 0001703384 · SVP, CAO and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,214

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-009023 · wk-form4_1771448783.xml · nonDerivative · entry 1

McDonnell Michael R. · CIK 0001121897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,811

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001628280-26-007418 · wk-form4_1770854998.xml · nonDerivative · entry 2

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,464

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.

F3 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-007418 · wk-form4_1770854998.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,689

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001628280-26-007420 · wk-form4_1770855065.xml · nonDerivative · entry 2

Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,006

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.

F3 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-007420 · wk-form4_1770855065.xml · nonDerivative · entry 1

Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,924

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001628280-26-007416 · wk-form4_1770854931.xml · nonDerivative · entry 2

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,846

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.

F3 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-26-007416 · wk-form4_1770854931.xml · nonDerivative · entry 1

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,616

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001628280-26-007413 · wk-form4_1770854857.xml · nonDerivative · entry 2

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,904

F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.

F3 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001628280-26-007413 · wk-form4_1770854857.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,048

F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.

SEC source: 0001628280-25-057326 · wk-form4_1765919171.xml · nonDerivative · entry 1

Mason Jeanne K · CIK 0001362109 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,853

F1 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of accelerated Federal Insurance Contributions Act (FICA) taxes for restricted stock unit awards previously granted under Baxter International Inc.'s Long-Term Incentive Plan.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-25-054990 · wk-form4_1764795854.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,151

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 1, 2025 from the settlement of vested restricted stock units granted on December 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001967368-25-000007 · wk-form4_1757023350.xml · nonDerivative · entry 1

Sonig Alok · CIK 0001967368 · EVP,Group President,Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,219

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2025 from the settlement of vested restricted stock units granted on September 1, 2022

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001940945-25-000008 · wk-form4_1757023311.xml · derivative · entry 3

Hider Andrew P. · CIK 0001940945 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,651

Underlying: Common Stock, $1 par value · 465,651 shares

Expires 2035-09-02

F3 · shares: The reporting person received stock options as a pro rata grant under Baxter's 2025 annual equity incentive compensation program, with such options becoming exercisable in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to the terms of the Plan.

F3 · derivative.exercise_date: The reporting person received stock options as a pro rata grant under Baxter's 2025 annual equity incentive compensation program, with such options becoming exercisable in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to the terms of the Plan.

SEC source: 0001940945-25-000008 · wk-form4_1757023311.xml · nonDerivative · entry 2

Hider Andrew P. · CIK 0001940945 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,050

F2 · shares: The reporting person received RSUs as a pro rata grant under Baxter's 2025 annual equity incentive compensation program that are scheduled to vest in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Plan.

SEC source: 0001940945-25-000008 · wk-form4_1757023311.xml · nonDerivative · entry 1

Hider Andrew P. · CIK 0001940945 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,237

F1 · shares: The reporting person received a grant of restricted stock units (RSUs) as compensation for the unvested portion of certain equity awards previously granted by the reporting person's prior employer (the Make Whole Award). The Make Whole Award is scheduled to vest in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. (Baxter) 2021 Amended and Restated Incentive Plan (the Plan). Any outstanding and unvested portion of the Make Whole Award will immediately vest if the reporting person's employment is terminated by Baxter other than for Cause (as defined in Baxter's Executive Severance Plan) or by the reporting person for Good Reason (as defined in the Offer Letter, effective as of July 7, 2025, by and between the reporting person and Baxter).

SEC source: 0001602507-25-000011 · wk-form4_1757023275.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,560

F1 · shares: The reporting person received a grant of restricted stock units (RSUs) that are scheduled to vest on September 5, 2028, the first business day following the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the Plan). The RSUs will immediately vest if the reporting person's employment is terminated without Cause (as defined in the Plan).

F2 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.